Cell Therapy in the Treatment of Solid Tumors

Cell therapy is an exciting new treatment option being used for patients with solid tumors, including melanoma, head and neck cancers, and non-small cell lung cancer, especially for patients with who have exhausted all other treatment options. In this webinar, Dr. Young Hong describes an example of this new modality called tumor infiltrating lymphocyte (TIL) cell therapy and his experience in the clinical setting at MD Anderson Cancer Center at Cooper. Dr. Hong also discusses how TIL therapy differs from what is being used in patients currently and how to select the appropriate patients for this new therapy. This webinar is targeted to health professionals - physicians, APNs/PAs, nurses, researchers, technicians, pharmacists, residents, and medical students. Please note there are no CME credits awarded for this event.